Atlas Trials

Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)

Clinical trial NCT03273712 · COMPLETED

Trial details

NCT number
NCT03273712
Sponsor
University of Iowa
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine TumorsMeningiomaNeuroblastomaMedulloblastoma
Start date
2017-09-29
Primary completion
2020-05-27
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.